These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3556742)

  • 21. Antimuscarinic activities of hycanthone analogs: possible relationship with animal toxicity.
    Gordon RK; Chiang PK
    J Pharmacol Exp Ther; 1986 Jan; 236(1):85-9. PubMed ID: 3484525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary investigations of some derivatives of oxamniquine.
    Karekezi CW; Lucas PD; Marples BA; Salt WG
    J Chemother; 1995 Apr; 7(2):133-5. PubMed ID: 7666119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of oxamniquine to the DNA of schistosomes.
    Pica-Mattoccia L; Cioli D; Archer S
    Trans R Soc Trop Med Hyg; 1989; 83(3):373-6. PubMed ID: 2617584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schistosoma mansoni: drug induced changes in the cell population of the vitelline gland.
    Erasmus DA; Popiel I
    Exp Parasitol; 1980 Oct; 50(2):171-87. PubMed ID: 7409071
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni.
    Haese WH; Bueding E
    J Pharmacol Exp Ther; 1976 Jun; 197(3):703-13. PubMed ID: 180276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined treatment of Biomphalaria glabrata infected by Schistosoma mansoni with oxamniquine and praziquantel: Reproductive histological and metabolic aspects.
    Lima RN; Coelho PMZ; Mattos ACA; Mello Silva CC; Augusto RC; Mota EM; de Souza S; Atella GC; Cabral SS; Gabriel Kluck GE; Faro MJ
    Exp Parasitol; 2017 Dec; 183():6-12. PubMed ID: 29017937
    [No Abstract]   [Full Text] [Related]  

  • 27. Resistance to oxamniquine of a Schistosoma mansoni strain isolated from patient submitted to repeated treatments.
    Coelho PM; Lima e Silva FC; Nogueira-Machado JA
    Rev Inst Med Trop Sao Paulo; 1997; 39(2):101-6. PubMed ID: 9394523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic complementation analysis of two independently isolated hycanthone-resistant strains of Schistosoma mansoni.
    Pica-Mattoccia L; Dias LC; Cioli D
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():211-4. PubMed ID: 1343897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure at inducing resistance to schistosomicidal drugs in a Brazilian human strain of Schistosoma mansoni.
    Dias LC; Olivier CE
    Rev Inst Med Trop Sao Paulo; 1986; 28(5):352-7. PubMed ID: 3589395
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparative study on the genetic effects of hycanthone and oxamniquine.
    Ray VA; Holden HE; Ellis JH; Hyneck ML
    J Toxicol Environ Health; 1975 Nov; 1(2):211-7. PubMed ID: 1107579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schistosomal Sulfotransferase Interaction with Oxamniquine Involves Hybrid Mechanism of Induced-fit and Conformational Selection.
    Ezebuo FC; Uzochukwu IC
    Curr Comput Aided Drug Des; 2020; 16(4):451-459. PubMed ID: 31284869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel.
    Bonesso-Sabadini PI; de Souza Dias LC
    Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):381-5. PubMed ID: 12048569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for the mode of antischistosomal action of hycanthone.
    Cioli D; Pica-Mattoccia L; Rosenberg S; Archer S
    Life Sci; 1985 Jul; 37(2):161-7. PubMed ID: 4010473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticholinergic properties of the antischistosomal drug hycanthone.
    Hillman GR; Senft AW
    Am J Trop Med Hyg; 1975 Sep; 24(5):827-34. PubMed ID: 1190369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug therapy of mansoni schistosomiasis].
    Zeitune JM; Ramos SR; Sugmyama LC; Côrte AA
    Arq Gastroenterol; 1980; 17(2):88-95. PubMed ID: 7213141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-schistosomal drugs: observations on the mechanism of drug resistance to hycanthone, and on the involvement of host antibodies in the mode of action of praziquantel.
    Brindley PJ; Sher A
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():157-61. PubMed ID: 3151089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance of schistosomes to hycanthone and oxamniquine.
    Cioli D; Pica-Mattoccia L; Archer S
    Mem Inst Oswaldo Cruz; 1989 Oct; 84 Suppl 1():38-45. PubMed ID: 2638729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modification of cytochrome P-450, NADPH-cytochrome c reductase and aryl hydrocarbon hydroxylase activities by schistosomicidal drugs.
    Mostafa MH; Swelem SM; Farag HF
    Biochem Pharmacol; 1989 Jan; 38(2):251-5. PubMed ID: 2492425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents.
    de Souza Dias LC; de Jesus Pedro R; Deberaldini ER
    Trans R Soc Trop Med Hyg; 1982; 76(5):652-9. PubMed ID: 7179419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of some new antibilharzial drugs on oxygen consumption of mouse diaphragm and liver homogenates in experimental bilharziasis.
    Amin SM; Hammouda NA; Habib YA; Mikhail AR; Hameid LA
    J Egypt Soc Parasitol; 1982 Jun; 12(1):107-14. PubMed ID: 7086209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.